Application
HLA-DOA Antibody (N-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the HLA-DOA antibody detected the HLA-DOA protein (arrow).| Product Name | HLA-DOA Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | HLA-DNA, HLA-DZA |
|---|---|
| Alternative Names | HLA-DOA HLA-DNA HLA-DZA HLA class II histocompatibility antigen DO alpha chain HLA class II histocompatibility antigen DO alpha chain MHC DN-alpha HLA class II histocompatibility antigen DO alpha chain MHC DZ alpha HLA class II histocompatibil |
| Molecular Weight(MW) | 27599 Da |
| Function | Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM |
| Tissue Specificity | This HLA-DOA Antibody Antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-59 amino acids from the N-term region of human HLA-DOA. |
| Cellular Localization | Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note=Complexes with HLA-DM molecule during intracellular transport and in endosomal/lysosomal compartments Heterotetramerization is necessary to exit the ER |
| Entrez Gene | 3111 |
|---|
Application
HLA-DOA Antibody (N-term) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the HLA-DOA antibody detected the HLA-DOA protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
